00:58:49 EDT Thu 01 Jun 2023
Enter Symbol
or Name

Login ID:
Titan Medical Inc (2)
Symbol TMD
Shares Issued 111,202,690
Close 2022-06-20 C$ 0.61
Recent Sedar Documents

Titan Medical, Nissha sign surgical consumable deal

2022-06-21 12:28 ET - News Release

Mr. Paul Cataford reports


Titan Medical Inc. has signed an agreement with Nissha Medical Technologies for the manufacture of surgical consumables. These single-use surgical components will be used for verification and validation testing, and preclinical and clinical studies of Titan's Enos robotic single access surgical system.

"We are pleased to be working with Nissha, experts in providing end-to-end solutions in product design, development, and manufacturing of single-use medical technologies for our Enos system," said Paul Cataford, interim president, chief executive officer and board chair. "This partnership is an important next step as we begin verification and validation testing later this year."

"Nissha Medical Technologies's vertically integrated design and manufacturing capabilities are what make this partnership such a great fit," said Tariq Abalis, vice-president of business development, Nissha Medical Technologies Design and Manufacturing. "We're looking forward to further supporting Titan Medical in their advancement of robotic assisted technology."

About Titan Medical Inc.

Titan Medical, a medical device company headquartered in Toronto, Ont., and with operations in Chapel Hill, N.C., is focused on enhancing robotic assisted surgery using innovative technology through a single access point. The Enos robotic single access surgical system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand and includes multiarticulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. With the Enos system, Titan intends to initially pursue gynecologic surgical indications.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.